At 6.4% CAGR, the Middle East & Africa Endoscopy Procedures Market is Projected to be Worth US$ 2,481.66 million by 2030, Says Business Market Insights

According to Business Market Insights research, the Middle East & Africa endoscopy procedures market was valued at US$ 1,512.40 million in 2022 and is expected to reach US$ 2,481.66 million by 2030, registering a CAGR of 6.4% from 2022 to 2030. Use of artificial intelligence (ai) in gastroenterology and increasing prevalence of cancer attributed to the Middle East & Africa endoscopy procedures market expansion.        

The application of artificial intelligence (AI) in gastrointestinal (GI) endoscopy is drawing a great amount of attention because it has the potential to improve the quality of endoscopy at all levels, compensating for human errors and limitations by bringing more accuracy, consistency, and higher speed. It will make a breakthrough and a big revolution in the development of GI endoscopy. AI has the advantage of limiting inter-operator variability. It can compensate for the limited experience of novice endoscopists and the errors of even the most experienced endoscopists. Over the past four decades, the incidence of esophageal adenocarcinoma (EAC) has risen rapidly due to the increasingly prevalent excess body weight. AI assistance shows promising results in terms of improving the detection and diagnosis of esophageal adenocarcinoma (EAC), thus, reducing the mortality and morbidity related to this type of malignancy with a poor prognosis when diagnosed at an advanced stage. The CAG AI SIG has an open model inviting new members, and AI researchers to maximize this novel technology's potential in improving endoscopy quality and patient outcomes. Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, developed the world’s first artificial intelligence (AI) platform to detect cancer. Its AI algorithms analyze images of biopsies and can pinpoint their location and grade the tumor. These results help pathologists diagnose gastric cancer accurately. Galen Gastric is an integrated diagnostics and quality control solution that supports pathologists in the detection of gastric cancer, dysplasia, H. pylori, and other important clinical findings. Thus, such development of AI-based endoscopes for cancer diagnostics are likely to introduce new trends in the endoscopy procedure market during the forecast period.

On the contrary, risks of infections associated with endoscopic procedures hampers the Middle East & Africa endoscopy procedures market.  

Based on procedure, the Middle East & Africa endoscopy procedures market is segmented into endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. The others segment held 24.4% share of Middle East & Africa endoscopy procedures market in 2022, amassing US$  368.73 million. It is projected to garner US$  587.01 million by 2030 to expand at 6.0% CAGR during 2022–2030. 

In terms of offering, the Middle East & Africa endoscopy procedures market is segmented into endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps’ traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and others. The endoscopes segment held 33.4% share of Middle East & Africa endoscopy procedures market in 2022, amassing US$ 505.57 million. It is projected to garner US$ 840.39 million by 2030 to expand at 6.6% CAGR during 2022–2030.

Based on product type, the Middle East & Africa endoscopy procedures market is bifurcated into disposable and reusable. The reusable segment held 79.1% share of Middle East & Africa endoscopy procedures market in 2022, amassing US$ 1,196.97 million. It is projected to garner US$ 1,850.68 million by 2030 to expand at 5.6% CAGR during 2022–2030.

In terms of end user, the Middle East & Africa endoscopy procedures market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. The hospitals and clinics segment held 60.2% share of Middle East & Africa endoscopy procedures market in 2022, amassing US$ 910.09 million. It is projected to garner US$ 1,476.97 million by 2030 to expand at 6.2% CAGR during 2022–2030.

By country, the Middle East & Africa endoscopy procedures market has been categorized into the Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 32.5% share of Middle East & Africa endoscopy procedures market in 2022. It was assessed at US$ 491.57 million in 2022 and is likely to hit US$  846.47 million by 2030, exhibiting a CAGR of 7.0% during 2022–2030.      

Key players operating in the Middle East & Africa endoscopy procedures market Stryker Corp, Smith & Nephew Plc, Arthrex Inc, Olympus Corp, Boston Scientific Corp, among others.

• The Stryker in May-2023, Mergers and Acquisitions  Stryker had completed the acquisition of Cerus Endovascular Ltd. The acquisition of Cerus Endovascular is highly complementary to Stryker’s Neurovascular business and strengthens the hemorrhagic portfolio globally.
• The Stryker in Jun-2022, Company News       Stryker had opened its new research and development facility, Stryker’s Global Technology Centre, at the International Tech Park, Gurgaon. The 150,000-square-foot facility further supported the company’s mission to make healthcare better.
• The Stryker in Feb-2022, Mergers and Acquisitions   Stryker had completed the acquisition of Vocera Communications, Inc. Vocera bring a highly complementary and innovative portfolio to Stryker’s Medical division that enhanced the company’s Advanced Digital Healthcare offerings and further advance Stryker’s focus on preventing adverse events throughout the continuum of care.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com